Yedlapati Siva H, Mendu Anuradha, Tummala Venkat R, Maganti Sowmith S, Nasir Khurram, Khan Safi U
Department of Medicine, Erie County Medical Center, 462 Grider Street, Buffalo, NY 14215, USA.
Department of Biology, Virginia Commonwealth University, 1000 W Cary St, Richmond, VA 23284, USA.
Eur Heart J Suppl. 2023 Feb 14;25(Suppl A):A17-A24. doi: 10.1093/eurheartjsupp/suac110. eCollection 2023 Feb.
Cardiovascular disease (CVD) is the leading cause of death in the world and is largely preventable. An increasing amount of evidence suggests that annual influenza vaccination reduces CVD-related morbidity and mortality. Despite various clinical guidelines recommending annual influenza vaccination for the general population for influenza-like illness risk reduction, with a particular emphasis on people with CVD, vaccination rates fall consistently below the goal established by the World Health Organization. This review outlines the importance of influenza vaccination, mechanisms of cardiovascular events in influenza, summarizing the available literature on the effects of influenza vaccine in CVD and the benefits of influenza vaccine during the COVID-19 pandemic.
心血管疾病（CVD）是全球主要的死亡原因，且在很大程度上是可预防的。越来越多的证据表明，每年接种流感疫苗可降低与心血管疾病相关的发病率和死亡率。尽管各种临床指南建议普通人群每年接种流感疫苗以降低患流感样疾病的风险，尤其强调心血管疾病患者，但疫苗接种率一直低于世界卫生组织设定的目标。本综述概述了流感疫苗接种的重要性、流感中心血管事件的机制，总结了关于流感疫苗对心血管疾病影响的现有文献以及在2019冠状病毒病大流行期间流感疫苗的益处。
